Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitis
Completed
- Conditions
- Acute, non-streptococcal tonsillopharyngitisEar, Nose and Throat
- Registration Number
- ISRCTN03930168
- Lead Sponsor
- ISO Arzneimittel GmbH & Co KG (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
The study took place between March and April 1997. It is terminated. Patients, who met the following inclusion criteria, were suitable for the trial:
1. Age 6-10 years
2. Acute exsudative tonsillopharyngitis
3. Duration of symptoms less than 48 h
4. No Group A Beta Hemolytic Streptococcus (GABHS)-infection
5. Tonsillopharyngitis Severity Score (TSS) 6 or more points, and
6. Informed consent in writing by legal guardians who were able to understand the nature, meaning and consequences of the trial
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method